Literature DB >> 15840671

Immunopathological changes in a uraemic rat model for peritoneal dialysis.

Mohammad Zareie1, An S De Vriese, Liesbeth H P Hekking, Piet M ter Wee, Casper G Schalkwijk, Bas A J Driesprong, Inge L Schadee-Eestermans, Robert H J Beelen, Norbert Lameire, Jacob van den Born.   

Abstract

BACKGROUND: Peritoneal dialysis (PD) is a treatment modality for patients with renal failure. Both the uraemic state of these patients and chronic exposure to PD fluid are associated with the development of functional and structural alterations of the peritoneal membrane. In a well-established chronic PD rat model, we compared rats with normal renal function with subtotal nephrectomized rats that developed uraemia.
METHODS: Uraemic and control rats received daily 10 ml conventional glucose containing PD fluid, via peritoneal catheters during a 6 week period. Uraemic and control rats receiving no PD fluid served as controls. Parameters relevant for peritoneal defence and serosal healing responses were analyzed.
RESULTS: Uraemic animals were characterized by 2-3-fold increased serum urea and creatinine levels, accompanied by a significantly reduced haematocrit. Uraemia (without PD fluid exposure) induced new blood vessels in different peritoneal tissues, accompanied by increased accumulation of advanced glycation end products (AGEs) and elevated levels of angiogenic factors such as vascular endothelial growth factor and monocyte chemoattractant protein-1 (MCP-1) in peritoneal lavage fluid. A much stronger peritoneal response was observed upon PD fluid exposure in non-uraemic rats. This included the induction of angiogenesis and fibrosis in various peritoneal tissues, accumulation of AGEs, immunological activation of the omentum, damage to the mesothelial cell layer, focal formation of granulation tissues and increased MCP-1 and hyaluronan levels in peritoneal lavage fluid. Finally, chronic PD fluid instillation in uraemic rats did not induce an additional peritoneal response compared to PD fluid exposure in non-uraemic rats, except for the degree of AGE accumulation.
CONCLUSIONS: Both uraemia and PD fluid exposure result in pathological alterations of the peritoneum. However, uraemia did not induce major additive effects to PD fluid-induced injury. These results substantially contribute to the understanding of the pathobiology of the peritoneum under PD conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15840671     DOI: 10.1093/ndt/gfh835

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  12 in total

Review 1.  A review of rodent models of peritoneal dialysis and its complications.

Authors:  Ji Wang; Shujun Liu; Hongyu Li; Jing Sun; Sijin Zhang; Xiaohong Xu; Yingying Liu; Yangwei Wang; Lining Miao
Journal:  Int Urol Nephrol       Date:  2014-11-26       Impact factor: 2.370

2.  Influence of colonic dialysis using Chinese medicine on creatinine decomposition by intestinal bacteria in uremia rats.

Authors:  Haidong He; Meilin Shen; Weiqian Sun; Yuyan Tang; Xudong Xu; Yan Xie
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

3.  Protective effect of COMP-angiopoietin-1 on peritoneal vascular permeability and peritoneal transport function in uremic peritoneal dialysis rats.

Authors:  Yuanyuan Shi; Yifan Xiong; Yutian Lei; Zhenyuan Li; Hao Yan; Jiangzi Yuan; Feng Ding; Wei Fang
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

Review 4.  Peritoneal changes in patients on long-term peritoneal dialysis.

Authors:  Raymond T Krediet; Dirk G Struijk
Journal:  Nat Rev Nephrol       Date:  2013-05-14       Impact factor: 28.314

5.  Peritoneal microvascular endothelial function and the microinflammatory state are associated with baseline peritoneal transport characteristics in uremic patients.

Authors:  Lanbo Teng; Ming Chang; Shuxin Liu; Min Niu; Yungang Zhang; Xiangfei Liu; Xiaoxia Yu
Journal:  Int Urol Nephrol       Date:  2014-07-08       Impact factor: 2.370

6.  Dyslipidemia and Intraperitoneal Inflammation Axis in Peritoneal Dialysis Patients: A Cross-Sectional Pilot Study.

Authors:  Natalia Stepanova; Victoria Driianska; Svitlana Savchenko
Journal:  Kidney Dis (Basel)       Date:  2019-11-06

7.  Bioincompatible impact of different peritoneal dialysis fluid components and therapeutic interventions as tested in a rat peritoneal dialysis model.

Authors:  Andrea W D Stavenuiter; Karima Farhat; Margot N Schilte; Piet M Ter Wee; Robert H J Beelen
Journal:  Int J Nephrol       Date:  2011-08-02

8.  Protection of the Peritoneal Membrane by Peritoneal Dialysis Effluent-Derived Mesenchymal Stromal Cells in a Rat Model of Chronic Peritoneal Dialysis.

Authors:  Lan Zhou; Ming Zong; Qiunong Guan; Gerald da Roza; Hao Wang; Hualin Qi; Caigan Du
Journal:  Stem Cells Int       Date:  2019-09-16       Impact factor: 5.443

9.  Tamoxifen and bone morphogenic protein-7 modulate fibrosis and inflammation in the peritoneal fibrosis model developed in uremic rats.

Authors:  Filipe M O Silva; Elerson C Costalonga; Cleonice Silva; Ana C O Carreira; Samirah A Gomes; Mari C Sogayar; Camilla Fanelli; Irene L Noronha
Journal:  Mol Med       Date:  2019-08-28       Impact factor: 6.354

Review 10.  Regulation of synthesis and roles of hyaluronan in peritoneal dialysis.

Authors:  Timothy Bowen; Soma Meran; Aled P Williams; Lucy J Newbury; Matthias Sauter; Thomas Sitter
Journal:  Biomed Res Int       Date:  2015-10-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.